Nottingham, United Kingdom

Farouk Shakib

This inventor holds 1 USPTO granted patent. Top assignee: Peptide Therapeutics Limited. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Farouk Shakib. Retrieved from https://idiyas.com/inventor/farouk-shakib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Farouk Shakib

Introduction

Farouk Shakib is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His work focuses on innovative solutions for medical treatments, showcasing his dedication to improving healthcare.

Latest Patents

Farouk Shakib holds a patent for "Cysteine protease inhibitors for use in treatment of IGE mediated." This patent represents his commitment to advancing medical science and providing new avenues for treatment.

Career Highlights

Shakib is associated with Peptide Therapeutics Limited, where he applies his expertise in peptide technology. His role at the company allows him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Some of his coworkers include Tony Johnson and Terrance Hart. Their collective efforts enhance the innovative environment at Peptide Therapeutics Limited.

Conclusion

Farouk Shakib's work exemplifies the spirit of innovation in biotechnology. His contributions through patents and collaboration with peers highlight the importance of teamwork in advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…